Stock 690 UNI-BIO SCIENCE GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Uni-Bio Science Group Limited

Equities

690

KYG9198H1406

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.085 HKD +7.59% Intraday chart for Uni-Bio Science Group Limited +2.41% +18.06%
Mar. 27 Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 14 Uni-Bio Science's Profit to Climb in 2023 MT

Business Summary

Uni-Bio Science Group Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.

Number of employees: 407

Sales per Business

HKD in Million2022Weight2023Weight Delta
Chemical Pharmaceutical Products
53.2 %
232 52.8 % 258 53.2 % +10.91%
Biological Pharmaceutical Products
46.8 %
208 47.2 % 227 46.8 % +9.16%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
440 100.0 % 485 100.0 % +10.08%

Managers

Managers TitleAgeSince
Zhi Gang Zhao CEO
 Chief Executive Officer 64 14-03-31
Wei Tian ADM
 Chief Administrative Officer 41 -
Jing Li CTO
 Chief Tech/Sci/R&D Officer 45 -
Kai Du AUD
 Comptroller/Controller/Auditor - 16-09-30
Huanan Zhao PRN
 Corporate Officer/Principal - -
Wen Du An SAM
 Sales & Marketing - -
Wing Yan Ho SEC
 Corporate Secretary 42 19-09-04

Members of the board

Members of the board TitleAgeSince
Zhi Gang Zhao CEO
 Chief Executive Officer 64 14-03-31
Da Wei Chen BRD
 Director/Board Member 54 17-01-12
Kingsley Leung CHM
 Chairman 37 13-07-07
Qing Shan Ma BRD
 Director/Board Member 44 19-04-07
Kai Ming Chow BRD
 Director/Board Member 58 16-03-31
Qi Min Ren BRD
 Director/Board Member 68 17-11-14
Kwok Wing Yau BRD
 Director/Board Member 49 19-04-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,163,588,147 2,811,247,245 ( 45.61 %) 0 45.61 %

Shareholders

NameEquities%Valuation
Kingsley Leung
26.79 %
1,650,971,464 26.79 % 17 M $
Heungkong Great Health Fund I LP
14.03 %
865,040,000 14.03 % 9 M $
Ru Feng He
10.66 %
657,180,000 10.66 % 7 M $
Da Wei Chen
2.776 %
171,094,438 2.776 % 2 M $
Zhi Gang Zhao
0.1307 %
8,055,000 0.1307 % 82 322 $
Qing Shan Ma
0.000000 %
0 0.000000 % - $
Kai Ming Chow
0.000000 %
0 0.000000 % - $
Qi Min Ren
0.000000 %
0 0.000000 % - $
Kwok Wing Yau
0.000000 %
0 0.000000 % - $

Company contact information

Uni-Bio Science Group Ltd.

Unit 502, 5/F No. 20 Science Park East Avenue

, Hong Kong

+

http://www.uni-bioscience.com
address Uni-Bio Science Group Limited(690)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
UNI-BIO SCIENCE GROUP LIMITED Stock Uni-Bio Science Group Limited
+18.06% 66.92M
CSL LIMITED Stock CSL Limited
-4.43% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.09% 15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 690 Stock
  4. Company Uni-Bio Science Group Limited